Mohammed H Al-Temimi1, Edwin G Kim2, Bindupriya Chandrasekaran2, Vanessa Franz2, Charles N Trujillo2, Asrai Mousa2, Deron J Tessier3, Samir D Johna2, David A Santos4. 1. Arrowhead Regional Medical Center, Colton, CA, USA; Kaiser Permanente Fontana Medical Center, Fontana, CA, USA. Electronic address: muhammidh.hussein@yahoo.com. 2. Arrowhead Regional Medical Center, Colton, CA, USA; Kaiser Permanente Fontana Medical Center, Fontana, CA, USA. 3. Arrowhead Regional Medical Center, Colton, CA, USA. 4. University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abstract
BACKGROUND: We compared endoscopic retrograde cholangiopancreatography (ERCP) and laparoscopic common bile duct exploration (LCBDE) for managing choledocholithiasis found at time of cholecystectomy. METHODS: One hundred and five LCBDE (2005-2015) were compared to 195 LC/ERCP (2014-2015) from the Southern California Kaiser Permanente database. RESULTS: LC/ERCP was more effective at clearing the CBD (98% vs. 88.6%, p = 0.01); but required more procedures per patient (mean ± standard deviation, 1.1 ± 0.4 vs. 2.0 ± 0.12, p < 0.001). Morbidity, hospital length of stay and readmission were not different (P > 0.05). Four patients failed ERCP, while 12 patients failed LCBDE and had subsequent ERCP (10) or CBD exploration (2). All patients with RYGB had successful LCBDE. CONCLUSION: LC/ERCP is better than LCBDE in clearing CBD stones, but has similar morbidity and is an effective alternative for patients with RYGB.
BACKGROUND: We compared endoscopic retrograde cholangiopancreatography (ERCP) and laparoscopic common bile duct exploration (LCBDE) for managing choledocholithiasis found at time of cholecystectomy. METHODS: One hundred and five LCBDE (2005-2015) were compared to 195 LC/ERCP (2014-2015) from the Southern California Kaiser Permanente database. RESULTS: LC/ERCP was more effective at clearing the CBD (98% vs. 88.6%, p = 0.01); but required more procedures per patient (mean ± standard deviation, 1.1 ± 0.4 vs. 2.0 ± 0.12, p < 0.001). Morbidity, hospital length of stay and readmission were not different (P > 0.05). Four patients failed ERCP, while 12 patients failed LCBDE and had subsequent ERCP (10) or CBD exploration (2). All patients with RYGB had successful LCBDE. CONCLUSION: LC/ERCP is better than LCBDE in clearing CBD stones, but has similar morbidity and is an effective alternative for patients with RYGB.
Authors: Rosa Jorba; Mihai C Pavel; Erik Llàcer-Millán; Laia Estalella; Mar Achalandabaso; Elisabet Julià-Verdaguer; Esther Nve; Erlinda D Padilla-Zegarra; Josep M Badia; Donal B O'Connor; Robert Memba Journal: Surg Endosc Date: 2020-09-23 Impact factor: 4.584
Authors: Matthew Connell; Warren Y L Sun; Valentin Mocanu; Jerry T Dang; Janice Y Kung; Noah J Switzer; Daniel W Birch; Shahzeer Karmali Journal: Surg Endosc Date: 2022-01-18 Impact factor: 3.453